Werner Mederski

This inventor holds 67 USPTO granted patents and 6 published patent applications, plus 5 CIPO patents and 14 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Merck Patent Gmbh, Merck Patent Gesellschaft MIT Beschrankter Haftung, Merck Patent Gesellschaft. Active years: 1993-2024.

USPTO Granted Patents = 67 (Patent Applications = 6)

% Patents Active = 53.7

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 8)

Average Co-Inventor Count = 5.4

ph-index = 10

Forward Citations = 379(Granted Patents)

Forward Citations (Not Self Cited) = 350(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Erzhauzen, DE (1998)
Erzhausen, DE (1993 - 2005)
Darmstadt, DE (1998 - 2007)
Zwingenberg, DE (2005 - 2024)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

3 out of 121

Merck Patent Gesellschaft

patents

4. 2 out of 77

3-Dimensional Pharmaceuticals, Inc.

patents

5. 1 out of 100

Merck Patent Gesellschaft MIT Beschraenkter Haftung

patents

6. 1 out of 363

Ortho-Mcneil Pharmaceutical Corp.

patents

7. 1 out of 834,411

Other

patents

Years Active: 1993-2024

Loading Chart...

Areas of Expertise:

Arylquinazolines

DNA-PK Inhibitors

Factor Xa Inhibitors

Morpholinyl Compounds

Imidazoquinolines

Carbonyl Compounds

Indazole Derivatives

Prolinyl Derivatives

Acyl Hydrazines

Thromboembolic Diseases

Antidiabetics

SGLT Inhibitors

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878967 - Crystalline forms of 1-(4-{[6-amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino]-methyl}-4-fluoro-piperidin-1-yl)-propenone, salt forms thereof, and processes to obtain (2024-01-23),

2. 11065253 - Arylquinazolines (2021-07-20),

3. 10383874 - Arylquinazolines (2019-08-20),

4. 10172859 - Arylquinazolines (2019-01-08),

5. 9732094 - Arylquinazolines (2017-08-15),

6. 9598408 - Imidazo[4,5-C]quinolines as DNA-PK inhibitors (2017-03-21),

7. 9187469 - Morpholinylbenzotriazines for use in cancer therapy (2015-11-17),

8. 9126952 - Morpholinylquinazolines (2015-09-08),

9. 9000153 - Imidazo[4,5-c]quinolines as DNA-PK inhibitors (2015-04-07),

10. 8815924 - Heterocyclic carbonyl compounds (2014-08-26),

11. 8802712 - Pyrazoloquinolines (2014-08-12),

12. 8278312 - [object Object] (2012-10-02),

13. 8258151 - 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors (2012-09-04),

14. 8153649 - 3-aminoimidazo 1,2-A pyridine derivatives having an SGLT1- and SGLT2-inhibiting action for the treatment of type 1 and type 2 diabetes (2012-04-10),

15. 8129373 - Carbonyl compounds (2012-03-06),

Title: The Innovative Journey of Werner Mederski

Introduction:

Werner Mederski, a visionary inventor hailing from Zwingenberg, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Werner Mederski's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable transportation, and advanced materials science, showcasing his commitment to creating a more sustainable future.

Career Highlights:

Throughout his illustrious career, Werner Mederski has been at the forefront of innovation, leading research and development teams to create revolutionary products that have reshaped industries. His keen eye for identifying gaps in the market and his dedication to solving complex problems have set him apart as a true pioneer in the world of invention.

Collaborations:

Werner Mederski has collaborated with leading universities, research institutions, and multinational corporations to bring his inventions to life. His ability to work seamlessly across different sectors and disciplines has led to the successful commercialization of numerous patented technologies.

Conclusion:

In conclusion, Werner Mederski's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a trailblazing inventor. His contributions to the world of technology continue to inspire future generations to think boldly and create fearlessly.